ArticleOncoimmunology2023

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).

A Daban et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.